NEW YORK (GenomeWeb News) – Atossa Genetics said today that it has signed up Millennium Healthcare to distribute its non-invasive breast cancer diagnostic test in the New York metro area and in northern New Jersey.

Under the agreement, Millennium Medical Devices will distribute and market Atossa's ForeCYTE Breast Health devices to managed-care networks, healthcare clinics, and physician practices.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.